Mutational analysis of TSC1 and TSC2 genes in gangliogliomas

Neuropathology and Applied Neurobiology

Volumn 27, Issue 2, 2001, Pages 105-114

  Becker, A J ^a   Lobach M ^a   Klein, H ^a   Normann, S ^a   Nothen M M ^b   Von Deimling, A ^a,c   Mizuguchi, M ^d   Elger, C E ^a   Schramm, J ^a   Wiestler, O D ^a   Blumcke I ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

^b UNIVERSITY OF BONN   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Epilepsy; Glioneuronal; Hamartin; Microdissection; Tuberin; Tumour

Indexed keywords

ARTICLE; CLINICAL ARTICLE; CLONE; CONTROLLED STUDY; DNA SEQUENCE; GENE MUTATION; GENETIC POLYMORPHISM; GLIA; GLIOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; TEMPORAL LOBE EPILEPSY;

BRAIN NEOPLASMS; CHRONIC DISEASE; DNA MUTATIONAL ANALYSIS; DNA PRIMERS; EPILEPSY, TEMPORAL LOBE; GANGLIOGLIOMA; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; POINT MUTATION; PROTEINS; REPRESSOR PROTEINS; TUMOR SUPPRESSOR PROTEINS;

EID: 0034951252     PISSN: 03051846     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0305-1846.2001.00302.x     Document Type: Article

References (41)

1. Mutational analysis of the tuberous sclerosis gene TSC2 in patients with pulmonary lymphangioleiomyomatosis
2. Mutations and polymorphisms in the tuberous sclerosis complex gene on chromosome 16
3. Exon scanning of the entire TSC2 gene for germline mutations in 40 unrelated patients with tuberous sclerosis
4. A device for processing large acrylamide gels
5. Evidence for developmental precursor lesions in epilepsy-associated glioneuronal tumors
6. 9q34 loss of heterozygosity in a tuberous sclerosis astrocytoma suggests a growth suppressor-like activity also for the TSC1 gene
7. Mutation and polymorphism analysis in the tuberous sclerosis 2 (TSC2) gene
8. Phenotypes of the tuberous sclerosis complex with a revision of diagnostic criteria
9. The tuberous sclerosis gene on chromosome 9q34 acts as a growth suppressor
10. Loss of heterozygosity on chromosome 16p13.3 in hamartomas from tuberous sclerosis patients
11. Loss of heterozygosity in the tuberous sclerosis (TSC2) region of chromosome band 16p13 occurs in sporadic as well as TSC-associated renal angiomyolipomas
12. Allelic loss is frequent in tuberous sclerosis kidney lesions but rare in brain lesions
13. Gigas, a Drosophila homolog of tuberous sclerosis gene product-2, regulates the cell cycle
14. Co-localization of TSC1 and TSC2 gene products in tubers of patients with tuberous sclerosis
15. Molecular genetic and phenotypic analysis reveals differences between TSC1 and TSC2 associated familial and sporadic tuberous sclerosis
16. Comprehensive mutation analysis of TSC1 and TSC2- and phenotypic correlations in 150 families with tuberous sclerosis
17. Hereditary cancer: Two hits revisited
18. Tuberin immunohistochemistry in brain, kidneys and heart with or without tuberous sclerosis
19. Novel cerebral lesions in the Eker rat model of tuberous sclerosis: Cortical tuber and anaplastic ganglioglioma
20. A novel splice site associated polymorphism in the tuberous sclerosis 2 (TSC2) gene may predispose to the development of sporadic gangliogliomas
21. Two loci for tuberous sclerosis: One on 9q34 and one on 16p13
22. Tuberous sclerosis
23. Pathology of tuberous sclerosis
24. Identification of expressed genes by laser-mediated manipulation of single cells
25. RNA splice junctions of different classes of eukaryotes: Sequence statistics and functional implications in gene expression
26. Identification and characterization of the tuberous sclerosis gene on chromosome 16
27. Presence of potent transcriptional activation domains in the predisposing tuberous sclerosis (TSC2) gene product of the Eker rat model
28. Mutations in the TSC2 gene: Analysis of the complete coding sequence using the protein truncation test (PTT)
29. Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34
30. Interaction between hamartin and tuberin, the TSC1 and TSC2 gene products
31. Mutational spectrum of the TSC1 gene in a cohort of 225 tuberous sclerosis complex patients: No evidence for genotype-phenotype correlation
32. Comprehensive allelotype and genetic analysis of 466 human nervous system tumors
33. Co-localization of the TSC2 product tuberin with its target Rap1 in the Golgi apparatus
34. Novel mutations detected in the TSC2 gene from both sporadic and familial TSC patients
35. Phenotypic heterogeneity associated with the splicing mutation in congenital adrenal hyperplasia due to 21-hydroxylase deficiency
36. Surgical pathology of chronic epileptic seizure disorders
37. Ganglioglioma: A detailed histopathological and immunohistochemical analysis of 61 cases
38. Tuberous sclerosis-like lesions in epileptogenic human neocortex lack allelic loss at the TSC1 and TSC2 regions
39. The tuberous sclerosis 2 gene product, tuberin, functions as a Rab5 GTPase activating protein (GAP) in modulating endocytosis